{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T11:00:45Z","timestamp":1790766045916,"version":"4.1.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,11,12]],"date-time":"2020-11-12T00:00:00Z","timestamp":1605139200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,11,12]],"date-time":"2020-11-12T00:00:00Z","timestamp":1605139200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP20dm0107119"],"award-info":[{"award-number":["JP20dm0107119"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Arch Psychiatry Clin Neurosci"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s00406-020-01208-w","type":"journal-article","created":{"date-parts":[[2020,11,12]],"date-time":"2020-11-12T11:03:06Z","timestamp":1605178986000},"page":"439-446","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Rapid-acting and long-lasting antidepressant-like action of (R)-ketamine in Nrf2 knock-out mice: a role of TrkB signaling"],"prefix":"10.1007","volume":"271","author":[{"given":"Youge","family":"Qu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajing","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijia","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaoyu","family":"Pu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfei","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8892-0439","authenticated-orcid":false,"given":"Kenji","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,12]]},"reference":[{"key":"1208_CR1","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nrn2297","volume":"9","author":"R Dantzer","year":"2008","unstructured":"Dantzer R, O\u2019Connor C, Freund GG, Johnson RW, Kelley KW (2008) From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 9:46\u201356","journal-title":"Nat Rev Neurosci"},{"key":"1208_CR2","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.brainresrev.2009.05.005","volume":"61","author":"K Hashimoto","year":"2009","unstructured":"Hashimoto K (2009) Emerging role of glutamate in the pathophysiology of major depressive disorder. Brain Res Rev 61:105\u2013123","journal-title":"Brain Res Rev"},{"key":"1208_CR3","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1001\/archgenpsychiatry.2010.161","volume":"67","author":"CL Raison","year":"2010","unstructured":"Raison CL, Lowry CA, Rook GA (2010) Inflammation, sanitation, and consternation: loss of contact with coevolved, tolerogenic microorganisms and the pathophysiology and treatment of major depression. Arch Gen Psychiatry 67:1211\u20131224","journal-title":"Arch Gen Psychiatry"},{"key":"1208_CR4","doi-asserted-by":"crossref","first-page":"7796","DOI":"10.3390\/ijms16047796","volume":"16","author":"K Hashimoto","year":"2015","unstructured":"Hashimoto K (2015) Inflammatory biomarkers as differential predictors of antidepressant response. Int J Mol Sci 16:7796\u20137801","journal-title":"Int J Mol Sci"},{"key":"1208_CR5","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/nri.2015.5","volume":"16","author":"AH Miller","year":"2016","unstructured":"Miller AH, Raison CL (2016) The role of inflammation in depression: from evolutionary imperative to modern treatment target. Nat Rev Immunol 16:22\u201334","journal-title":"Nat Rev Immunol"},{"key":"1208_CR6","doi-asserted-by":"crossref","first-page":"721","DOI":"10.2174\/1570159X14666160119094646","volume":"14","author":"JC Zhang","year":"2016","unstructured":"Zhang JC, Yao W, Hashimoto K (2016) Brain-derived neurotrophic factor (BDNF) \u2013 TrkB signaling in inflammation-related depression and potential therapeutic targets. Curr Neuropharmacol 14:721\u2013731","journal-title":"Curr Neuropharmacol"},{"key":"1208_CR7","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.neuron.2020.06.002","volume":"107","author":"E Beurel","year":"2020","unstructured":"Beurel E, Toups M, Nemeroff CB (2020) The bidirectional relationship of depression and inflammation: double trouble. Neuron 107:234\u2013256","journal-title":"Neuron"},{"key":"1208_CR8","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.biopsych.2009.09.033","volume":"67","author":"Y Dowlati","year":"2010","unstructured":"Dowlati Y, Hermann N, Swardfager W, Liu H, Sham L, Reim EK, Lanct\u00f4t KL (2010) A meta-analysis of cytokines in major depression. Biol Psychiatry 67:446\u2013457","journal-title":"Biol Psychiatry"},{"key":"1208_CR9","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jad.2014.07.032","volume":"169","author":"JJ Young","year":"2014","unstructured":"Young JJ, Bruno D, Pomara N (2014) A review of the relationship between pro-inflammatory cytokines and major depressive disorder. J Affect Disord 169:15\u201320","journal-title":"J Affect Disord"},{"key":"1208_CR10","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.bbi.2015.06.001","volume":"49","author":"R Haapakoski","year":"2015","unstructured":"Haapakoski R, Mathieu J, Ebmeiner KP, Alenius H, Kivim\u00e4ki M (2015) Cumulative meta-analysis of interleukins 6 and 1\u03b2, tumour necrosis factor \u03b1 and C-reactive protein in patients with major depressive disorder. Brain Behav Immun 49:206\u2013215","journal-title":"Brain Behav Immun"},{"key":"1208_CR11","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/bs.irn.2019.12.004","volume":"152","author":"MA Nettis","year":"2020","unstructured":"Nettis MA, Pariante CM (2020) Is there neuroinflammation in depression? Understanding the link between the brain and the peripheral immune system in depression. Int Rev Neurobiol 152:23\u201340","journal-title":"Int Rev Neurobiol"},{"key":"1208_CR12","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1042\/BST20150069","volume":"43","author":"MA O'Connell","year":"2015","unstructured":"O\u2019Connell MA, Hayes JD (2015) The Keap1\/Nrf2 pathway in health and disease: from the bench to the clinic. Biochem Soc Trans 43:687\u2013689","journal-title":"Biochem Soc Trans"},{"key":"1208_CR13","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.freeradbiomed.2015.06.006","volume":"88","author":"T Suzuki","year":"2015","unstructured":"Suzuki T, Yamamoto M (2015) Molecular basis of the Keap1-Nrf2 system. Free Radic Biol Med 88:93\u2013100","journal-title":"Free Radic Biol Med"},{"key":"1208_CR14","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1042\/BST20150014","volume":"43","author":"JD Wardyn","year":"2015","unstructured":"Wardyn JD, Ponsford AH, Sanderson CM (2015) Dissecting molecular cross-talk between Nrf2 and NF-\u03baB response pathways. Biochem Soc Trans 43:621\u2013626","journal-title":"Biochem Soc Trans"},{"key":"1208_CR15","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.3389\/fphar.2018.01182","volume":"9","author":"K Hashimoto","year":"2018","unstructured":"Hashimoto K (2018) Essential role of Keap1-Nrf2 signaling in mood disorders: overview and future perspective. Front Pharmacol 9:1182","journal-title":"Front Pharmacol"},{"key":"1208_CR16","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1152\/physrev.00023.2017","volume":"98","author":"M Yamamoto","year":"2018","unstructured":"Yamamoto M, Kensler TW, Motohashi H (2018) The Keap1-Nrf2 system: a thiol-based sensor-effector apparatus for maintaining redox homeostasis. Physiol Rev 98:1169\u20131203","journal-title":"Physiol Rev"},{"key":"1208_CR17","first-page":"e00099","volume":"40","author":"L Baird","year":"2020","unstructured":"Baird L, Yamamoto M (2020) The molecular mechanisms regulating the Keap1-Nrf2 pathway. Mol Cell Biol 40:e00099-e120","journal-title":"Mol Cell Biol"},{"key":"1208_CR18","doi-asserted-by":"crossref","first-page":"30659","DOI":"10.1038\/srep30659","volume":"6","author":"W Yao","year":"2016","unstructured":"Yao W, Zhang JC, Ishima T, Dong C, Yang C, Ren Q, Ma M, Han M, Wu J, Suganuma H, Ushida Y, Yamamoto M, Hashimoto K (2016) Role of Keap1-Nrf2 signaling in depression and dietary intake of glucoraphanin confers stress resilience in mice. Sci Rep 6:30659","journal-title":"Sci Rep"},{"key":"1208_CR19","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jnutbio.2016.10.004","volume":"39","author":"JC Zhang","year":"2017","unstructured":"Zhang JC, Yao W, Dong C, Yang C, Ren Q, Ma M, Han M, Wu J, Ushida Y, Suganuma H, Hashimoto K (2017) Prophylactic effects of sulforaphane on depression-like behavior and dendritic changes in mice after inflammation. J Nutr Biochem 39:134\u2013144","journal-title":"J Nutr Biochem"},{"key":"1208_CR20","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1007\/s00406-017-0848-0","volume":"268","author":"JC Zhang","year":"2018","unstructured":"Zhang JC, Yao W, Dong C, Han M, Shirayama Y, Hashimoto K (2018) Keap1-Nrf2 signaling pathway confers resilience versus susceptibility to inescapable electric stress. Eur Arch Psychiatry Clin Neurosci 268:865\u2013870","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"1208_CR21","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.neuron.2019.02.005","volume":"101","author":"JH Krystal","year":"2019","unstructured":"Krystal JH, Abdallah CG, Sanacora G, Charney DS, Duman RS (2019) Ketamine: a paradigm shift for depression research and treatment. Neuron 101:774\u2013778","journal-title":"Neuron"},{"key":"1208_CR22","doi-asserted-by":"crossref","first-page":"112628","DOI":"10.1016\/j.bbr.2020.112628","volume":"390","author":"CG Abdallah","year":"2020","unstructured":"Abdallah CG, Krystal JH (2020) Ketamine and rapid acting antidepressants: are we ready to cure, rather than treat depression? Behav Brain Res 390:112628","journal-title":"Behav Brain Res"},{"key":"1208_CR23","doi-asserted-by":"crossref","first-page":"112631","DOI":"10.1016\/j.bbr.2020.112631","volume":"390","author":"E Lavender","year":"2020","unstructured":"Lavender E, Hirasawa-Fujita M, Domino EF (2020) Ketamine\u2019s dose related multiple mechanisms of actions: dissociative anesthetic to rapid-antidepressant. Behav Brain Res 390:112631","journal-title":"Behav Brain Res"},{"key":"1208_CR24","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1080\/14737175.2019.1554434","volume":"19","author":"K Zhang","year":"2019","unstructured":"Zhang K, Hashimoto K (2019) An update on ketamine and its two enantiomers as rapid-acting antidepressants. Expert Rev Neurother 19:83\u201392","journal-title":"Expert Rev Neurother"},{"key":"1208_CR25","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.pbb.2013.11.033","volume":"116","author":"JC Zhang","year":"2014","unstructured":"Zhang JC, Li SX, Hashimoto K (2014) R (\u2212)-ketamine shows greater potency and longer lasting antidepressant effects than S (+)-ketamine. Pharmacol Biochem Behav 116:137\u2013141","journal-title":"Pharmacol Biochem Behav"},{"key":"1208_CR26","doi-asserted-by":"crossref","first-page":"e632","DOI":"10.1038\/tp.2015.136","volume":"5","author":"C Yang","year":"2015","unstructured":"Yang C, Shirayama Y, Zhang JC, Ren Q, Yao W, Ma M, Dong C, Hashimoto K (2015) R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects. Transl Psychiatry 5:e632","journal-title":"Transl Psychiatry"},{"key":"1208_CR27","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1124\/jpet.116.239228","volume":"361","author":"K Fukumoto","year":"2017","unstructured":"Fukumoto K, Toki H, Iijima M, Hashihayata T, Yamaguchi J, Hashimoto K, Chaki S (2017) Antidepressant potential of (R)-ketamine in rodent models: comparison with (S)-ketamine. J Pharmacol Exp Ther 361:9\u201316","journal-title":"J Pharmacol Exp Ther"},{"key":"1208_CR28","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.biopsych.2017.05.016","volume":"83","author":"C Yang","year":"2018","unstructured":"Yang C, Ren Q, Qu Y, Zhang JC, Ma M, Dong C, Hashimoto K (2018) Mechanistic target of rapamycin-independent antidepressant effects of (R)-ketamine in a social defeat stress model. Biol Psychiatry 83:18\u201328","journal-title":"Biol Psychiatry"},{"key":"1208_CR29","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.pbb.2019.04.008","volume":"181","author":"L Chang","year":"2019","unstructured":"Chang L, Zhang K, Pu Y, Qu Y, Wang SM, Xiong Z, Ren Q, Dong C, Fujita Y, Hashimoto K (2019) Comparison of antidepressant and side effects in mice after intranasal administration of (R, S)-ketamine, (R)-ketamine, and (S)-ketamine. Pharmacol Biochem Behav 181:53\u201359","journal-title":"Pharmacol Biochem Behav"},{"key":"1208_CR30","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.psychres.2016.03.034","volume":"239","author":"C Yang","year":"2016","unstructured":"Yang C, Han M, Zhang JC, Ren Q, Hashimoto K (2016) Loss of parvalbumin-immunoreactivity in mouse brain regions after repeated intermittent administration of esketamine, but not R-ketamine. Psychiatry Res 239:281\u2013283","journal-title":"Psychiatry Res"},{"key":"1208_CR31","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s00406-016-0692-7","volume":"267","author":"K Hashimoto","year":"2017","unstructured":"Hashimoto K, Kakiuchi T, Ohba H, Nishiyama S, Tsukada H (2017) Reduction of dopamine D2\/3 receptor binding in the striatum after a single administration of esketamine, but not R-ketamine: a PET study in conscious monkeys. Eur Arch Psychiatry Clin Neurosci 267:173\u2013176","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"1208_CR32","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.pbb.2018.07.003","volume":"172","author":"Z Tian","year":"2018","unstructured":"Tian Z, Dong C, Fujita A, Fujita Y, Hashimoto K (2018) Expression of heat shock protein HSP-70 in the retrosplenial cortex of rat brain after administration of (R, S)-ketamine and (S)-ketamine, but not (R)-ketamine. Pharmacol Biochem Behav 172:17\u201321","journal-title":"Pharmacol Biochem Behav"},{"key":"1208_CR33","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jad.2020.03.040","volume":"269","author":"Y Tan","year":"2020","unstructured":"Tan Y, Hashimoto K (2020) Risk of psychosis after repeated intermittent administration of (S)-ketamine, but not (R)-ketamine, in mice. J Affect Disord 269:198\u2013200","journal-title":"J Affect Disord"},{"key":"1208_CR34","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0924-977X(96)00042-9","volume":"7","author":"FX Vollenweider","year":"1997","unstructured":"Vollenweider FX, Leenders KL, Oye I, Hell D, Angst J (1997) Differential psychopathology and patterns of cerebral glucose utilisation produced by (S)- and (R)-ketamine in healthy volunteers using positron emission tomography (PET). Eur Neuropsychopharmacol 7:25\u201338","journal-title":"Eur Neuropsychopharmacol"},{"key":"1208_CR35","doi-asserted-by":"publisher","DOI":"10.1007\/s00406-020-01110-5","author":"GC Leal","year":"2020","unstructured":"Leal GC, Bandeira ID, Correia-Melo FS, Telles M, Mello RP, Vieira F, Lima CS, Jesus-Nunes AP, Guerreiro-Costa LNF, Marback RF, Caliman-Fontes AT, Marques BLS, Bezerra MLO, Dias-Neto AL, Silva SS, Sampaio AS, Sanacora G, Turecki G, Loo C, Lacerda ALT, Quarantini LC (2020) Intravenous arketamine for treatment-resistant depression: open-label pilot study. Eur Arch Psych Clin Neurosci. https:\/\/doi.org\/10.1007\/s00406-020-01110-5","journal-title":"Eur Arch Psych Clin Neurosci"},{"key":"1208_CR36","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/pcn.12902","volume":"73","author":"K Hashimoto","year":"2019","unstructured":"Hashimoto K (2019) Rapid-acting antidepressant ketamine, its metabolites and other candidates: a historical overview and future perspective. Psychiatry Clin Neurosci 73:613\u2013627","journal-title":"Psychiatry Clin Neurosci"},{"key":"1208_CR37","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/s41398-019-0624-1","volume":"9","author":"C Yang","year":"2019","unstructured":"Yang C, Yang J, Luo A, Hashimoto K (2019) Molecular and cellular mechanisms underlying the antidepressant effects of ketamine enantiomers and its metabolites. Transl Psychiatry 9:280","journal-title":"Transl Psychiatry"},{"key":"1208_CR38","doi-asserted-by":"crossref","first-page":"172870","DOI":"10.1016\/j.pbb.2020.172870","volume":"190","author":"Y Wei","year":"2020","unstructured":"Wei Y, Chang L, Hashimoto K (2020) A historical review of antidepressant effects of ketamine and its enantiomers. Pharmacol Biochem Behav 190:172870","journal-title":"Pharmacol Biochem Behav"},{"key":"1208_CR39","doi-asserted-by":"crossref","first-page":"113935","DOI":"10.1016\/j.bcp.2020.113935","volume":"177","author":"K Hashimoto","year":"2020","unstructured":"Hashimoto K (2020a) Molecular mechanisms of the rapid-acting and long-lasting antidepressant actions of (R)-ketamine. Biochem Pharmacol 177:113935","journal-title":"Biochem Pharmacol"},{"key":"1208_CR40","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nature10130","volume":"475","author":"AE Autry","year":"2011","unstructured":"Autry AE, Adachi M, Nosyreva E, Na ES, Los MF, Cheng PF, Kavalali ET, Monteggia LM (2011) NMDA receptor blockade at rest triggers rapid behavioral antidepressant responses. Nature 475:91\u201395","journal-title":"Nature"},{"key":"1208_CR41","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.neuropharm.2015.10.034","volume":"102","author":"C Bj\u00f6rkholm","year":"2015","unstructured":"Bj\u00f6rkholm C, Monteggia LM (2015) BDNF- a key transducer of antidepressant effects. Neuropharmacology 102:72\u201379","journal-title":"Neuropharmacology"},{"key":"1208_CR42","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00213-015-4128-2","volume":"233","author":"WX Liu","year":"2016","unstructured":"Liu WX, Wang J, Xie ZM, Xu N, Zhang GF, Jia M, Zhou ZQ, Hashimoto K, Yang JJ (2016) Regulation of glutamate transporter 1 via BDNF-TrkB signaling plays a role in the anti-apoptotic and antidepressant effects of ketamine in chronic unpredictable mild stress model of depression. Psychopharmacology 233:405\u2013415","journal-title":"Psychopharmacology"},{"key":"1208_CR43","doi-asserted-by":"crossref","first-page":"e741","DOI":"10.1038\/tp.2016.21","volume":"6","author":"HL Sun","year":"2016","unstructured":"Sun HL, Zhou ZQ, Zhang GF, Yang C, Wang XM, Shen JC, Hashimoto K, Yang JJ (2016) Role of hippocampal p11 in the sustained antidepressant effect of ketamine in the chronic unpredictable mild stress model. Transl Psychiatry 6:e741","journal-title":"Transl Psychiatry"},{"key":"1208_CR44","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.3389\/fphar.2019.01702","volume":"10","author":"S Li","year":"2020","unstructured":"Li S, Luo X, Hua D, Wang Y, Zhan G, Huang N, Jiang R, Yang L, Zhu B, Yuan X, Luo A, Yang C (2020) Ketamine alleviates postoperative depression-like symptoms in susceptible mice: the role of BDNF-TrkB signaling. Front Pharmacol 10:1702","journal-title":"Front Pharmacol"},{"key":"1208_CR45","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s00406-020-01095-1","volume":"270","author":"K Hashimoto","year":"2020","unstructured":"Hashimoto K (2020b) Brain-derived neurotrophic factor -TrkB signaling and the mechanism of antidepressant activity by ketamine in mood disorders. Eur Arch Psychiatry Clin Neurosci 270:137\u2013138","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"1208_CR46","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1006\/bbrc.1997.6943","volume":"236","author":"K Itoh","year":"1997","unstructured":"Itoh K, Chiba T, Takahashi S, Ishii T, Igarashi K, Katoh Y, Oyake T, Hayashi N, Satoh K, Hatayama I, Yamamoto M, Nabeshima Y (1997) An Nrf2\/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem Biphys Res Commun 236:313\u2013322","journal-title":"Biochem Biphys Res Commun"},{"key":"1208_CR47","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1172\/JCI43992","volume":"121","author":"M Cazorla","year":"2011","unstructured":"Cazorla M, Pr\u00e9mont J, Mann A, Girad N, Kellendonk C, Rognan D (2011) Identification of a low-molecular weight TrkB antagonist with anxiolytic and antidepressant activity in mice. J Clin Invest 121:1846\u20131857","journal-title":"J Clin Invest"},{"key":"1208_CR48","first-page":"pyu077","volume":"18","author":"JC Zhang","year":"2014","unstructured":"Zhang JC, Wu J, Fujita Y, Yao W, Ren Q, Yang C, Li SX, Shirayama Y, Hashimoto K (2014) Antidepressant effects of TrkB ligands on depression-like behavior and dendritic changes in mice after inflammation. Int J Neuropsychopharmacol 18:pyu077","journal-title":"Int J Neuropsychopharmacol"},{"key":"1208_CR49","doi-asserted-by":"crossref","first-page":"e666","DOI":"10.1038\/tp.2015.157","volume":"5","author":"Q Ren","year":"2015","unstructured":"Ren Q, Ma M, Yang C, Zhang JC, Yao W, Hashimoto K (2015) BDNF-TrkB signaling in the nucleus accumbens shell of mice has key role in methamphetamine withdrawal symptoms. Transl Psychiatry 5:e666","journal-title":"Transl Psychiatry"},{"key":"1208_CR50","doi-asserted-by":"crossref","first-page":"4325","DOI":"10.1007\/s00213-015-4062-3","volume":"232","author":"JC Zhang","year":"2015","unstructured":"Zhang JC, Yao W, Dong C, Yang C, Ren Q, Ma M, Han M, Hashimoto K (2015) Comparison of ketamine, 7,8-dihydroxyflavone, and ANA-12 antidepressant effects in the social defeat stress model of depression. Psychopharmacology 232:4325\u20134335","journal-title":"Psychopharmacology"},{"key":"1208_CR51","doi-asserted-by":"crossref","first-page":"15725","DOI":"10.1038\/s41598-017-16060-7","volume":"7","author":"Y Qu","year":"2017","unstructured":"Qu Y, Yang C, Ren Q, Ma M, Dong C, Hashimoto K (2017) Comparison of (R)-ketamine and lanicemine on depression-like phenotype and abnormal composition of gut microbiota in a social defeat stress model. Sci Rep 7:15725","journal-title":"Sci Rep"},{"key":"1208_CR52","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1186\/s12974-020-01916-z","volume":"17","author":"S Wang","year":"2020","unstructured":"Wang S, Ishima T, Zhang J, Qu Y, Chang L, Pu Y, Fujita Y, Tan Y, Wang X, Hashimoto K (2020) Ingestion of Lactobacillus intestinalis and Lactobacillus reuteri causes depression- and anhedonia-like phenotypes in antibiotic-treated mice via the vagus nerve. J Neuroinflammation 17:241","journal-title":"J Neuroinflammation"},{"key":"1208_CR53","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1126\/science.1222939","volume":"338","author":"RS Duman","year":"2011","unstructured":"Duman RS, Aghajanian GK (2011) Synaptic dysfunction in depression: potential therapeutic targets. Science 338:68\u201372","journal-title":"Science"},{"key":"1208_CR54","doi-asserted-by":"crossref","first-page":"206","DOI":"10.2174\/1566524015666150330143008","volume":"15","author":"Y Ohgi","year":"2015","unstructured":"Ohgi Y, Futamura T, Hashimoto K (2015) Glutamate signaling in synaptogenesis and NMDA receptors as potential therapeutic targets for psychiatric disorders. Curr Mol Med 15:206\u2013221","journal-title":"Curr Mol Med"},{"key":"1208_CR55","doi-asserted-by":"crossref","first-page":"pyu121","DOI":"10.1093\/ijnp\/pyu121","volume":"18","author":"C Yang","year":"2015","unstructured":"Yang C, Shirayama Y, Zhang JC, Ren Q, Hashimoto K (2015) Regional differences in brain-derived neurotrophic factor levels and dendritic spine density confer resilience to inescapable stress. Int J Neuropsychopharmacol 18:pyu121","journal-title":"Int J Neuropsychopharmacol"},{"key":"1208_CR56","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1093\/ijnp\/pyz048","volume":"22","author":"J Zhang","year":"2019","unstructured":"Zhang J, Qu Y, Chang L, Pu Y, Hashimoto K (2019) (R)-ketamine rapidly ameliorates the decreased spine density in the medial prefrontal cortex and hippocampus of susceptible mice after chronic social defeat stress. Int J Neuropsychopharmacol 22:675\u2013679","journal-title":"Int J Neuropsychopharmacol"},{"key":"1208_CR57","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1016\/j.euroneuro.2015.09.002","volume":"25","author":"Y Shirayama","year":"2015","unstructured":"Shirayama Y, Yang C, Zhang JC, Ren Q, Yao W, Hashimoto K (2015) Alterations in brain-derived neurotrophic factor (BDNF) and its precursor proBDNF in the brain regions of a learned helplessness rat model and the antidepressant effects of a TrkB agonist and antagonist. Eur Neuropsychopharmacol 25:2449\u20132458","journal-title":"Eur Neuropsychopharmacol"},{"key":"1208_CR58","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1186\/s12974-018-1294-2","volume":"15","author":"D Mart\u00edn-Hern\u00e1ndez","year":"2018","unstructured":"Mart\u00edn-Hern\u00e1ndez D, Caso JR, Javier Meana J, Callado LF, Madrigal JLM, Garc\u00eda-Bueno B, Leza JC (2018) Intracellular inflammatory and antioxidant pathways in postmortem frontal cortex of subjects with major depression: effect of antidepressants. J Neuroinflammation 15:251","journal-title":"J Neuroinflammation"},{"key":"1208_CR59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000362841","volume":"70","author":"I Lukic","year":"2014","unstructured":"Lukic I, Mitic M, Djordjevic J, Tatalovic N, Bozovic N, Soldatovic I, Mihaljevic M, Pavlovic Z, Radojcic MB, Maric NP, Adzic M (2014) Lymphocyte levels of redox-sensitive transcription factors and antioxidative enzymes as indicators of pro-oxidative state in depressive patients. Neuropsychobiology 70:1\u20139","journal-title":"Neuropsychobiology"},{"key":"1208_CR60","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.jad.2018.12.016","volume":"245","author":"CH Lin","year":"2019","unstructured":"Lin CH, Huang MW, Lin CH, Huang CH, Lane HY (2019) Altered mRNA expressions for N-methyl-d-aspartate receptor-related genes in WBC of patients with major depressive disorder. J Affect Disord 245:1119\u20131125","journal-title":"J Affect Disord"},{"key":"1208_CR61","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12974-019-1695-x","volume":"17","author":"LL Qiu","year":"2020","unstructured":"Qiu LL, Pan W, Luo D, Zhang GF, Zhou ZQ, Sun XY, Yang JJ, Ji MH (2020) Dysregulation of BDNF\/TrkB signaling mediated by NMDAR\/Ca2+\/calpain might contribute to postoperative cognitive dysfunction in aging mice. J Neuroinflammation 17:23","journal-title":"J Neuroinflammation"}],"container-title":["European Archives of Psychiatry and Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00406-020-01208-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00406-020-01208-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00406-020-01208-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,20]],"date-time":"2021-03-20T12:08:36Z","timestamp":1616242116000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00406-020-01208-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,12]]},"references-count":61,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["1208"],"URL":"https:\/\/doi.org\/10.1007\/s00406-020-01208-w","relation":{},"ISSN":["0940-1334","1433-8491"],"issn-type":[{"value":"0940-1334","type":"print"},{"value":"1433-8491","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,12]]},"assertion":[{"value":"13 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Dr. Hashimoto is an inventor on a filed patent application on \u201cThe use of <i>R<\/i>-ketamine in the treatment of psychiatric diseases\u201d by Chiba University. Other authors have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}